Výsledky vyhledávání

Do Glucagonlike Peptide-1 Receptor Agonist and Sodium-glucose Co-transporter 2 Inhibitor Prescriptions in Germany Reflect Recommendations for Type 2 Diabetes with Cardiovascular Disease of the ADA/EASD Consensus Report?

Autor: Sebastian Dietmar Barth, Karel Kostev, Magdalene Krensel, Elke Mathey, Wolfgang Rathmann

Publikováno v: Experimental and Clinical Endocrinology & Diabetes. 131:153-161

Objectives To analyze whether prescription use of GLP-1RA and SGLT2i in individuals with type 2 diabetes with cardiovascular disease (CVD) has increased after the ADA/EASD consensus guidelines (2018) in a German Real-World setting and which clinical

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e05da8fc6704f386d8d061be81b87d3
https://doi.org/10.1055/a-1927-4454

Zobrazit plný text záznamu

Changes of Glucagonlike Peptide-1 Receptor Agonist (GLP-1 RA) and Sodium-glucose Co-transporter 2 Inhibitor (SGLT2i) prescription rates in Germany after the ADA/EASD Consensus Report: A Retrospective Study

Autor: Sebastian Barth, Karel Kostev, Magdalene Krensel, Elke Mathey, Wolfgang Rathmann

Publikováno v: Hand in Hand zum Ziel – einfach.besser.messbar www.diabeteskongress.de.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b9f7650d09d37b8aafa19e8275ae8346
https://doi.org/10.1055/s-0042-1746404

Zobrazit plný text záznamu

P1.22: Evaluation of responses to a questionnaire for parents of children with cancer during the years 1996 to 2002

Autor: Claudia Spix, Peter Kaatsch, Joachim Schüz, Elke Mathey

Publikováno v: Biometrical Journal. 46:106-106

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::44f1e27cec477adec316d0c0d4952a19
https://doi.org/10.1002/bimj.200490163

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání